Annual Total Long Term Liabilities
$5.97 M
+$1.97 M+49.27%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual total long term liabilities is $5.97 million, with the most recent change of +$1.97 million (+49.27%) on December 1, 2023.
- During the last 3 years, KPRX annual total long term liabilities has risen by +$2.38 million (+66.25%).
- KPRX annual total long term liabilities is now -83.61% below its all-time high of $36.41 million, reached on December 31, 2012.
Performance
KPRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$4.95 M
-$1.10 M-18.24%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly total long term liabilities is $4.95 million, with the most recent change of -$1.10 million (-18.24%) on September 1, 2024.
- Over the past year, KPRX quarterly long term liabilities has dropped by -$740.00 thousand (-13.00%).
- KPRX quarterly long term liabilities is now -86.40% below its all-time high of $36.41 million, reached on December 31, 2013.
Performance
KPRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KPRX Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +49.3% | -13.0% |
3 y3 years | +66.3% | +13.6% |
5 y5 years | +303.3% | +13.6% |
KPRX Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +51.4% | -18.2% | +28.8% |
5 y | 5-year | at high | +187.6% | -23.9% | +138.6% |
alltime | all time | -83.6% | -100.0% | -86.4% | -100.0% |
Kiora Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.95 M(-18.2%) |
Jun 2024 | - | $6.06 M(+1.9%) |
Mar 2024 | - | $5.94 M(-0.4%) |
Dec 2023 | $5.97 M(+49.3%) | $5.97 M(+4.9%) |
Sep 2023 | - | $5.69 M(+30.6%) |
Jun 2023 | - | $4.36 M(+3.4%) |
Mar 2023 | - | $4.22 M(+5.5%) |
Dec 2022 | $4.00 M(+1.4%) | $4.00 M(-3.6%) |
Sep 2022 | - | $4.15 M(+7.9%) |
Jun 2022 | - | $3.84 M(-0.3%) |
Mar 2022 | - | $3.86 M(-2.1%) |
Dec 2021 | $3.94 M(+9.8%) | $3.94 M(-36.3%) |
Sep 2021 | - | $6.19 M(-0.4%) |
Jun 2021 | - | $6.21 M(-4.6%) |
Mar 2021 | - | $6.51 M(+81.3%) |
Dec 2020 | $3.59 M(+73.0%) | $3.59 M(+52.5%) |
Sep 2020 | - | $2.35 M(0.0%) |
Jun 2020 | - | $2.35 M(+13.4%) |
Mar 2020 | - | $2.08 M(0.0%) |
Dec 2019 | $2.08 M | $2.08 M(+40.2%) |
Sep 2019 | - | $1.48 M(0.0%) |
Jun 2019 | - | $1.48 M(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $1.48 M(0.0%) |
Dec 2018 | $1.48 M(+5.8%) | $1.48 M(+6.2%) |
Sep 2018 | - | $1.39 M(-0.1%) |
Jun 2018 | - | $1.40 M(-0.1%) |
Mar 2018 | - | $1.40 M(-0.1%) |
Dec 2017 | $1.40 M(-49.2%) | $1.40 M(-49.0%) |
Sep 2017 | - | $2.74 M(-0.1%) |
Jun 2017 | - | $2.75 M(-0.1%) |
Mar 2017 | - | $2.75 M(-0.1%) |
Dec 2016 | $2.75 M(>+9900.0%) | $2.75 M(+127.4%) |
Sep 2016 | - | $1.21 M(0.0%) |
Jun 2016 | - | $1.21 M(>+9900.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(-100.0%) |
Dec 2014 | $36.41 M(0.0%) | $36.41 M(0.0%) |
Sep 2014 | - | $36.41 M(0.0%) |
Jun 2014 | - | $36.41 M(0.0%) |
Mar 2014 | - | $36.41 M(0.0%) |
Dec 2013 | $36.41 M(0.0%) | $36.41 M |
Dec 2012 | $36.41 M | - |
FAQ
- What is Kiora Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Kiora Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Kiora Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of KPRX is $5.97 M
What is the all time high annual total long term liabilities for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual total long term liabilities is $36.41 M
What is Kiora Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, KPRX annual total long term liabilities has changed by +$1.97 M (+49.27%)
What is Kiora Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of KPRX is $4.95 M
What is the all time high quarterly long term liabilities for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly total long term liabilities is $36.41 M
What is Kiora Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, KPRX quarterly total long term liabilities has changed by -$740.00 K (-13.00%)